The U.S. Court of Appeals for the Second Circuit in New York has ruled as unconstitutional a Vermont law banning the sale, transmission, or use of prescriber-identifiable data for marketing or promoting a prescription drug unless the prescriber consents.

Drug database firms IMS Health Inc., Verispan LLC, and SDI Health LLC, along with the Pharmaceutical Research and Manufacturers of America trade association, filed the suit.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access